What is Mark Griffin's NPI number?

Mark Griffin's National Provider Identifier (NPI) is 1164416251, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Mark Griffin's specialty?

Mark Griffin is listed in the NPPES registry with a primary specialty of Specialist (Other Service Providers).

Where is Mark Griffin located?

Mark Griffin's practice location on file with NPPES is 4545 R St, Lincoln, NE 68503-3723.

What is Mark Griffin's phone number?

The practice phone number listed in the NPPES registry for Mark Griffin is (402) 465-4545.

Does Mark Griffin accept Medicare?

Mark Griffin is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Mark Griffin's NPI active?

Yes — Mark Griffin's NPI (1164416251) is active in the NPPES registry as of the last update on 2014-09-18.

IndividualActiveAccepts Medicare

Mark Griffin, MD

NPI 1164416251 · Specialist · Lincoln, NE

Mark Griffin, MD is a Specialist provider in Lincoln, NE (NPI 1164416251).

Provider details

NPI number: 1164416251
Entity type: Individual
Primary specialty: SpecialistOther Service Providers
Credential: MD
Sex: Male
Sole proprietor: No
License: 19772 (NE)

Practice location

4545 R St

Lincoln, NE 68503-3723

Phone: (402) 465-4545

Fax: (402) 465-3621

Street-level locationGet directions

More NE providers

Mailing address

4545 R St

Lincoln, NE 68503-3723

Specialties & taxonomies

SpecialistPrimary174400000XLicense 19772 (NE)
Other Service Providers

Enrolled with Medicare as Practitioner - Gastroenterology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Detailed profile(76/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
21 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
1,395 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Removal of Polyps Or Growths of Large Bowel Using an Endoscope With Mechanical Snare45385	393	$235
Biopsy of Esophagus, Stomach, And/Or Upper Small Bowel Using a Flexible Endoscope43239	155	$86
Subsequent Hospital Care With Moderate Levelof Medical Decision Making, If Using Time, at Least 35 Minutes99232	149	$77
Insertion of Guide Wire With Dilation of Esophagus Using a Flexible Endoscope43248	77	$142
Biopsy of Large Bowel Using a Flexible Endoscope45380	74	$86
Initial Hospital Care With Moderate Level of Medical Decision Making, If Using Time, at Least 75 Minutes

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 26 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Sodium, Potassium,mag Sulfatesbrand: Sod Sulf-Potass Sulf-Mag Sulf	419	414
Omeprazole	327	112
Pantoprazole Sodium	183	63
Famotidine	80	21
Colestipol Hcl	46	23
Peg3350/Sod Sulf,bicarb,cl/Kclbrand: Gavilyte-G	38	37
Ondansetron Hcl	32	14

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$988 across 42 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2005-09-06
Last updated: 2014-09-18

Frequently asked questions

What is Mark Griffin's NPI number?: Mark Griffin's National Provider Identifier (NPI) is 1164416251, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Mark Griffin's specialty?: Mark Griffin is listed in the NPPES registry with a primary specialty of Specialist (Other Service Providers).
Where is Mark Griffin located?: Mark Griffin's practice location on file with NPPES is 4545 R St, Lincoln, NE 68503-3723.
What is Mark Griffin's phone number?: The practice phone number listed in the NPPES registry for Mark Griffin is (402) 465-4545.
Does Mark Griffin accept Medicare?: Mark Griffin is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Mark Griffin's NPI active?: Yes — Mark Griffin's NPI (1164416251) is active in the NPPES registry as of the last update on 2014-09-18.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Removal of Polyps Or Growths of Large Bowel Using an Endoscope With Mechanical Snare45385	393	$235
Biopsy of Esophagus, Stomach, And/Or Upper Small Bowel Using a Flexible Endoscope43239	155	$86
Subsequent Hospital Care With Moderate Levelof Medical Decision Making, If Using Time, at Least 35 Minutes99232	149	$77
Insertion of Guide Wire With Dilation of Esophagus Using a Flexible Endoscope43248	77	$142
Biopsy of Large Bowel Using a Flexible Endoscope45380	74	$86
Initial Hospital Care With Moderate Level of Medical Decision Making, If Using Time, at Least 75 Minutes

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 26 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Sodium, Potassium,mag Sulfatesbrand: Sod Sulf-Potass Sulf-Mag Sulf	419	414
Omeprazole	327	112
Pantoprazole Sodium	183	63
Famotidine	80	21
Colestipol Hcl	46	23
Peg3350/Sod Sulf,bicarb,cl/Kclbrand: Gavilyte-G	38	37
Ondansetron Hcl	32	14

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$988 across 42 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments